HelathTech startup Jutro Medical secures €12 million in Series A funding led by KAYA VC and RIO ASI, with participation from existing investor Inovo VC. The funding includes a debt component provided by mBank.
👯 Founders: Adam Janczewski
📅 Founding year: 2020
🏭 Industry: Healthcare
💥 Problem: Traditional telemedicine is inefficient, with doctors handling administrative tasks instead of focusing on patient care.
📣 Solution: AI-powered medical agents automate over 68% of teleconsultations, reducing appointment times and allowing doctors to focus on treatment.
👥 Customers: 70,000 patients, aiming for 350,000 within next two years
🌱 Stage: Series A
💰 Investment amount: €12 million
🚀 Funded by: KAYA VC, RIO ASI, Inovo VC, with a debt component from mBank
👁️🗨️ Investor’s perspective:
“AI will benefit incumbents, and Adam has positioned Jutro Medical to capture maximum value as the technology matures. He has quietly tested what’s possible using LLMs, with 30 people acting as medical agents, to map processes directly into the company’s proprietary electronic health record system. We’re excited to partner with Adam and his team as they transform healthcare services into AI-powered software products, directly benefiting patients and doctors,” says Karel Zheng, Partner at KAYA VC.
💡 It will be spent on: Further development of medical AI agents and expansion across Europe, particularly in the Netherlands and Poland.
💬 In their own words:
“We are building medical AI agents who can take over all these tasks from doctors, allowing them to finally practice medicine.” — Adam Janczewski, CEO & Founder
💪 Their specialty: AI-driven primary care, integrating online and offline healthcare with proprietary AI agents.
🔑 Business model: Vertically integrated healthcare provider offering AI-enhanced primary care under Europe’s public health insurance system.
👩🏫 Market: European primary healthcare sector
📊 Traction: 70,000 patients, 400,000 visits, 4.93/5 average rating, 86 NPS, 77% PMF score
💰 Funding so far: €9.08 million
